iScience (Dec 2021)

Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases

  • Yuxiu Xu,
  • Erlong Liu,
  • Xialin Xie,
  • Jiuru Wang,
  • Huaguo Zheng,
  • Ying Ju,
  • Lizhao Chen,
  • Changfei Li,
  • Xuyu Zhou,
  • Zihai Li,
  • Xin Li,
  • Songdong Meng

Journal volume & issue
Vol. 24, no. 12
p. 103445

Abstract

Read online

Summary: Upregulation and stabilization of Foxp3 expression in Tregs are essential for regulating Treg function and immune homeostasis. In this study, gp96 immunization showed obvious therapeutic effects in a Lyn–/– mouse model of systemic lupus erythematosus. Moreover, gp96 alleviated the initiation and progression of MOG-induced experimental autoimmune encephalomyelitis. Immunization of gp96 increased Treg frequency, expansion, and suppressive function. Gene expression profiling identified the NF-κB family member p65 and c-Rel as the key transcription factors for enhanced Foxp3 expression in Treg by gp96. Mutant gp96 within its Toll-like receptor (TLR) binding domain, TLR2 knockout mice, and mice with cell-specific deletion of MyD88, were used to demonstrate that gp96 activated Tregs and induced Foxp3 expression via a TLR2-MyD88-mediated NF-κB signaling pathway. Taken together, these results show that gp96 immunization restricted antibody-induced and Th-induced autoimmune diseases by integrating Treg expansion and activation, indicating its potential clinical usefulness against autoimmune diseases.

Keywords